(Q33392205)

English

Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

object named as

Kihyun Kim

4

0 references

author name string

Marcelo Iastrebner

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jun Ho Jang

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Elsa Nucifora

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Federico Sackmann

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dong Hwan Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sergio Orlando

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chul Won Jung

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ana Basquiera

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Graciela Klein

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fernando Santini

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Haydee I Bernard

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jorge Korin

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gustavo Taborda

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

7 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2250-2257

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Myelodysplastic syndromes: From pathogenesis and prognosis to treatment

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Decitabine in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Superiority of prolonged low-dose azanucleoside administration? Results of 5-aza-2'-deoxycytidine retreatment in high-risk myelodysplasia patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Cellular differentiation, cytidine analogs and DNA methylation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

The incidence and impact of thrombocytopenia in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.524324

21 January 2018

Identifiers

10.3109/10428194.2010.524324

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33392205&oldid=1536438305"